OrbiMed Comments on Takeda Pharmaceutical Company Limited Proxy Ahead of 143rd Ordinary General Meeting of Shareholders 2019
NEW YORK–(BUSINESS WIRE)–OrbiMed Advisors LLC (“OrbiMed”) has evaluated the proxy voting recommendations from both Institutional Shareholder Services Inc. (“ISS”) and…